Eficacia de Cimicifuga racemosa para el tratamiento de la clínica vasomotora y psíquica en pacientes menopáusicas

CM (40 mg/day) is a safe and effective alternative for the treatment of climacteric symptoms in women who cannot or do not wish to receive hormone replacement therapy.